Related references
Note: Only part of the references are listed.Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
Hagop Kantarjian et al.
BLOOD (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study
Anders Wahlin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine.: A randomized population-based phase II study
G Juliusson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)